These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29562982)

  • 1. High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana.
    Shin SS; Modongo C; Zetola NM; Wang Q; Phologolo T; Kestler M; Ho-Foster A
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):366-370. PubMed ID: 29562982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.
    Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Mosimaneotsile B; Motsamai OI; Shang N; Rose CE; Shepherd J
    AIDS; 2015 Jan; 29(3):351-9. PubMed ID: 25686683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
    Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
    Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
    BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
    Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
    BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid-associated hepatitis in adults infected with HIV receiving 36 months of isoniazid prophylaxis in Botswana.
    Tedla Z; Nguyen ML; Sibanda T; Nyirenda S; Agizew TB; Girde S; Rose CE; Samandari T
    Chest; 2015 May; 147(5):1376-1384. PubMed ID: 25340318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
    Smith T; Samandari T; Abimbola T; Marston B; Sangrujee N
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e84-93. PubMed ID: 26258564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Arscott-Mills T; Masole L; Ncube R; Steenhoff AP
    Int J Tuberc Lung Dis; 2017 May; 21(5):586-591. PubMed ID: 28399975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid for preventing tuberculosis in HIV-infected children.
    Zunza M; Gray DM; Young T; Cotton M; Zar HJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006418. PubMed ID: 28850172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
    Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
    AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
    Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
    PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.
    Onyango DO; van der Sande MAB; Yuen CM; Mecha J; Matemo D; Oele E; Kinuthia J; John-Stewart G; LaCourse SM
    J Int AIDS Soc; 2022 Aug; 25(8):e25939. PubMed ID: 35927793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid preventive therapy programmes for healthcare workers in India: translating evidence into policy.
    Raj R; Prasad H; Arya BK; Bhattacharya SD
    Natl Med J India; 2011; 24(4):201-7. PubMed ID: 22208138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
    Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
    BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.